LAKEWOOD, Colo.--(BUSINESS WIRE)-- Terumo BCT has received clearance for the preparation of plasma held at 1° to 6° C within 8 hours and frozen within 24 hours after phlebotomy (PF24) and plasma held ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Vanderbilt University Medical Center and The Royal Children’s Hospital in Melbourne, Australia (RCH) are driving toward new possibilities with help from Terumo BCT’s ...
Terumo Blood and Cell Technologies (Terumo BCT) is teaming up with Eliaz Therapeutics Inc. to develop and commercialize a new type of apheresis treatment for acute kidney injury (AKI) and ...
Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths [1, 2] and taking more lives than cancer [3]. This is more than ...
The recent blood shortage in the U.S.—exacerbated by the COVID-19 pandemic and a plummeting number of donations—has had a particularly strong effect on the growing demand for platelets, which help ...
“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...
The fifth annual Apheresis Awareness Day is recognized on Tuesday, September 17, 2024, as designated by the American Society for Apheresis (ASFA). The purpose is to raise awareness of apheresis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results